Therefore, this study suggests that auranofin can potentially prevent NAFLD by preventing the progression of NAFLD via NOX4-mediated NLRP3 inflammasome. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.